$RLFTF DD (opinion) by Rich B: Well, the pandemic
Post# of 653
The vaccines have given this false impression, and it is the common spoken word.
In my opinion, this is ridiculous.
Case counts are higher today than ever.
A high percentage of people are refusing the vaccines.
The vaccines’ length of efficacy is entirely unknown.
SARS-CoV-2 has mutated with variants, as viruses do, from the start, and is likely a long term, if not permanent, issue.
I initially viewed investing in Relief or NeuroRx as a short term play.
Now, I believe the opposite is true. When COPD is talked about in conjunction with RLF-100 (and ARDS in general), this has become a long term investment with a great amount of future potential.
Patience will be rewarded.